IRADIMED CORP (IRMD)
US46266A1097 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M | |||
| Marketable Securities | N/A | 0.00 | 500.00K | 1.91M | 2.77M | |||
| Receivables | 12.22M | 13.53M | 8.44M | 7.05M | 8.66M | |||
| Inventories | 12.82M | 5.37M | 4.30M | 3.93M | 3.64M | |||
| Other Current Assets | 1.19M | 630.00K | 1.00M | 770.00K | 410.00K | |||
| Total Current Assets | 76.00M | 77.49M | 76.24M | 63.74M | 58.96M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.33M | 4.61M | 4.55M | 4.84M | 5.01M | |||
| Intangibles | 2.52M | 2.07M | 1.12M | 960.00K | 860.00K | |||
| Other Non-Current Assets | 2.30M | 1.35M | 970.00K | 1.53M | 1.90M | |||
| Total Non-Current Assets | 16.15M | 8.02M | 6.64M | 7.33M | 7.77M | |||
| TOTAL ASSETS | 92.16M | 85.51M | 82.88M | 71.07M | 66.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.31M | 3.29M | 3.23M | 2.07M | 3.00M | |||
| Accounts Payable | 1.86M | 1.80M | 780.00K | 660.00K | 990.00K | |||
| Other Current Liabilities | 11.16M | 3.47M | 2.81M | 2.19M | 1.86M | |||
| Total Current Liabilities | 16.33M | 8.55M | 6.82M | 4.92M | 5.86M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.41M | 3.29M | 3.88M | 4.76M | 5.35M | |||
| Total Non-Current Liabilities | 4.41M | 3.29M | 3.89M | 4.76M | 5.34M | |||
| TOTAL LIABILITIES | 20.74M | 11.84M | 10.71M | 9.68M | 11.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 43.26M | 47.26M | 46.99M | 37.67M | 36.30M | |||
| Additional Paid In Capital | 28.16M | 26.41M | 25.16M | 23.68M | 19.19M | |||
| Common Shares | 1.27K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 0.00 | 20.00K | N/A | 30.00K | |||
| Shares Outstanding | 12.66M | 12.59M | 12.54M | 12.31M | 11.77M | |||
| Tangible Book Value per Share | 5.44 | 5.69 | 5.67 | 4.91 | 4.64 | |||
| Total Shareholders' Equity | 71.42M | 73.67M | 72.17M | 61.38M | 55.52M | |||
| TOTAL LIABILITIES AND EQUITY | 92.16M | 85.51M | 82.88M | 71.07M | 66.73M | |||
| Statistics | ||||||||
| Current Ratio | 4.65 | 9.06 | 11.18 | 12.96 | 10.06 | |||
| Return On Assets (ROA) | 18.66% | 15.00% | 11.26% | 1.93% | 14.43% | |||
| Return On Equity (ROE) | 24.07% | 17.42% | 12.93% | 2.23% | 17.35% | |||
| Return On Invested Capital (ROIC) | 20.92% | 16.08% | 10.22% | N/A | 11.25% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 60.87% | 65.15% | 57.35% | N/A | 46.85% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 67.38% | 73.11% | 62.51% | N/A | 49.78% | |||
All data in USD